ZTS ZOETIS INC.
XNYS
79.99
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ZTS
$79.99
—
Key stats
$79.99
- 52-Week Range
- $68.77 – $132.49
- YTD
- -36.47%
- IV Rank (30D)
- 22.27
- Straddle Price
- $7.80
- P/C Vol Ratio
- 0.70
- Market Cap
- $33.9B
- Open
- $79.00
- Day Range
- $78.63 – $80.67
- Volume
- 3,004,861
- Prev Close
- $82.11
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.95% |
| Beta vs SPY | 0.84 |
| Cost of Equity (CAPM) | 9.16% (VRP-adj) |
| WACC | 8.43% |
| Volatility Risk Premium | +40.4pp (IV − HV30) |
| Effective Tax Rate | 20.1% |
| Rev. Growth (YoY, DCF input) | -8.0% |
| DCF Horizon | 12 years explicit + fade |
| Free Cash Flow (TTM) | $2.4B |
| Return on Equity (TTM) | 83.1% |
| Book / Price | 9.0% |
| Gross Margin (TTM) | 71.8% |
| FCF Margin (TTM) | 24.9% |
| Debt / Equity | 2.80 |
| Quality Score | 4/6 — high quality (12y DCF) |
| Market-Implied Growth | +3.3% (reverse-DCF on current price) |
| SMA 50 | $75.60 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $79.66 |
| Bollinger Width / SMA20 | 21.1% (drives anchor stability) |
| Net Debt | $7.1B |
| Market Cap | $36B |
Peers used for multiples: ABBV, BMY, IDXX, JNJ, LLY, MRK, PFE, UNH
60-Day Conviction
83%
20-Day Fair Value
≈ by Dec 7, 2026
$80.91
α +0.7%
rank 28%
conviction
55%
40-Day Fair Value
≈ by Jan 5, 2027
$82.29
α +2.4%
rank 28%
conviction
77%
60-Day Fair Value
≈ by Feb 3, 2027
$82.82
α +3.1%
rank 34%
conviction
83%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $30.74 | 22% | |
| DDM (Gordon) | $11.33 | 17% | |
| Peer P/E | $269.30 | 10% | median 44.7× · 8 peers |
| Peer EV/EBITDA | $168.19 | 10% | median 19.9× · 8 peers |
| Peer P/B | $60.13 | 2% | median 8.2× · 7 peers |
| Peer P/S | $132.97 | 6% | median 6.1× · 8 peers |
| Market Anchor (SMA50) | $75.60 | 19% | stability 44% (BB-width) |
| Options Expected (B-L 30d) | $82.33 | 14% | 13 strikes · skew -0.15 |
As of 2026-11-06 · updated
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNYS
- Market Cap
- $33.9B
- Employees
- 14,500
- List Date
- 2013-02-01
- CIK
- 0001555280
- Headquarters
- Parsippany, NJ
- Homepage
- https://www.zoetis.com
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -5.71% | -14.63% | 12.69% | -4.46% | 5.10% | -0.87% | -1.31% |
| Feb | -0.22% | -2.62% | -0.48% | 4.86% | -2.73% | 4.93% | 0.62% |
| Mar | -0.13% | -2.05% | -0.67% | -11.32% | -3.45% | -8.34% | -4.33% |
| Apr | 9.59% | -7.25% | 4.84% | -4.66% | -3.40% | -1.98% | -0.48% |
| May | 0.82% | -2.14% | -9.22% | 6.98% | 8.34% | -31.95% | -4.53% |
| Jun | 6.99% | 2.92% | 3.74% | 0.57% | -7.95% | -7.35% | -0.18% |
| Jul | 7.08% | 4.79% | 10.49% | 4.32% | -8.42% | 5.93% | 4.03% |
| Aug | 1.21% | -12.91% | 2.70% | 0.59% | 6.12% | 0.00% | -0.38% |
| Sep | -5.96% | -6.98% | -9.63% | 6.43% | -4.29% | -9.61% | -5.01% |
| Oct | 10.20% | -0.38% | -9.11% | -8.04% | -1.95% | 15.37% | 1.01% |
| Nov | 3.95% | 0.93% | 16.66% | -3.68% | -11.20% | -3.44%* | 0.54% |
| Dec | 11.09% | -6.44% | 10.18% | -7.85% | -1.12% | -- | 1.17% |
| Total | 44.06% | -39.25% | 31.76% | -16.93% | -23.85% | -37.15% | -6.89% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $79.93
SMA 50: $75.71
SMA 200: $92.50
Current: $80.36
EMA 12: $81.29
EMA 26: $79.04
MACD: 2.2435 | Signal: 0.1532
BULLISH
ADX (14): 34.02
TREND
+DI: 33.72
−DI: 23.73
Momentum Oscillators
RSI (14): 52.92
NEUTRAL
Stoch %K: 55.95
Stoch %D: 76.31
Williams %R: -72.84
Volume & Volatility
BB Upper: $86.27
BB Lower: $73.60
NEUTRAL
OBV: -102,848,593
Vol SMA 20: 4,326,521
Vol ROC: 4.85%
ATR: $2.73
True Range: $3.48
HV 20: 50.3%
HV 30: 42.7%
HV 60: 36.2%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-07T00:00:00 – 2026-11-05T00:00:00
AI Analysis
Here is my response:
LLM Stock Analysis Report for ZTS
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers: Technical signals are mixed, with a bearish MACD signal and neutral RSI levels. News sentiment is overwhelmingly negative due to the recent class action lawsuits.
Primary Risks: Negative news sentiment and potential volatility spikes due to the lawsuit-related headlines.
Investment Thesis: ZTS is trading within a range bound by its SMA 200 and Bollinger Bands, indicating low volatility. However, the bearish MACD signal and negative news sentiment may lead to further price consolidation or a breakdown below the current support level.
Recent News Sentiment Impact: The recent class action lawsuits have led to a strong negative sentiment bias in the market, which could impact ZTS's stock price performance.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): NEUTRAL
- Medium-term (1-3 months): BEARISH
- Long-term (3-12 months): NEUTRAL
Support/Resistance Levels: The current support level is around $73.64, with resistance at $77.99.
Momentum Signals:
- RSI interpretation: Neutral (51.87)
- MACD signal: Bearish (-0.35 / Signal: 0.51 / Histogram: -0.86)
- Bollinger Bands position: Squeeze
Volume Analysis: Volume has been trending downward, with a recent spike in put volume.
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines are all related to class action lawsuits against ZTS, highlighting negative sentiment.
Sentiment Assessment: NEGATIVE (Strongly bearish bias due to lawsuit-related headlines)
Catalyst Identification: Upcoming deadline for the class action lawsuits (July 27th).
Market Narrative: The negative news sentiment is likely to continue impacting ZTS's stock price performance until the lawsuit-related issues are resolved.
Risk & Volatility Assessment
Beta Interpretation: Low volatility relative to the market (beta: 0.61).
Volatility Regime: Current volatility is low, but potential spikes cannot be ruled out due to the lawsuit-related headlines.
Options Market Signals:
- IV rank: Medium (26.4%)
- Put/call ratios: Bearish sentiment (1.47)
- Unusual activity: None
Downside Protection: The current support level is around $73.64, with potential for further price consolidation or a breakdown below this level.
Market Context & Positioning
Sector Performance: ZTS's sector (Healthcare) has been performing relatively well, which could provide some cushion against the negative news sentiment.
Institutional Activity: Institutional interest is low due to the recent lawsuit-related headlines.
Correlation Analysis: ZTS's stock price performance is negatively correlated with the market, indicating potential for further declines if the negative news sentiment persists.
Relative Valuation: ZTS is trading within a range bound by its SMA 200 and Bollinger Bands, indicating relatively low volatility. However, the bearish MACD signal and negative news sentiment may lead to further price consolidation or a breakdown below the current support level.
Key Levels & Action Items
Critical Price Levels: Support at $73.64, resistance at $77.99.
Breakout/Breakdown Levels: A breakout above $77.99 could trigger further gains, while a breakdown below $73.64 could lead to deeper price declines.
Time-Sensitive Catalysts: Upcoming deadline for the class action lawsuits (July 27th).
Risk Management: Consider setting stop-loss levels around $72.50 and position sizing accordingly given the negative news sentiment.
Overall, my analysis suggests that ZTS's stock price performance is likely to be impacted by the negative news sentiment related to the class action lawsuits. While the technical signals are mixed, the bearish MACD signal and low institutional interest may lead to further price consolidation or a breakdown below the current support level. Risk management considerations include setting stop-loss levels around $72.50 and position sizing accordingly given the negative news sentiment.
Generated
News
All ZTS news →
Fast lifecycle approvals, such as Simparica Duo, are how Zoetis plans to extend its core franchises beyond today's pressured pet care market.
Competitive pressure eased in dermatology, but clinic visits softened
Zoetis stock reversed lower at the open Thursday after the pet health giant reported "generally fine" third-quarter metrics, an analyst said. The post No Greyhounds Here: Pet-Health Giant Zoetis Reverses 30% Monthlong Sprint appeared first on Investor's Business Daily .
Showing 1–10 of 13
Page 1 of 2
Earnings History
17 of 23 under expected move
Avg Expected Move
6.85%
Avg Actual Move
5.54%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-05-06 | Pre-Market | 4.43% | 3.65% | 0.82x | Within |
| 2021-08-05 | Pre-Market | 4.87% | 0.46% | 0.09x | Within |
| 2021-11-04 | Pre-Market | 4.73% | 3.14% | 0.66x | Within |
| 2022-02-15 | Pre-Market | 4.63% | 0.68% | 0.15x | Within |
| 2022-05-05 | Pre-Market | 6.51% | 3.06% | 0.47x | Within |
| 2022-08-04 | Pre-Market | 5.02% | 3.25% | 0.65x | Within |
| 2022-11-03 | Pre-Market | 8.34% | 11.01% | 1.32x | Exceeded |
| 2023-02-14 | Pre-Market | 4.37% | 5.37% | 1.23x | Exceeded |
| 2023-05-04 | Pre-Market | 5.51% | 0.42% | 0.08x | Within |
| 2023-08-08 | Pre-Market | 5.78% | 4.77% | 0.83x | Within |
| 2023-11-02 | Pre-Market | 5.65% | 6.25% | 1.11x | Exceeded |
| 2024-02-13 | Pre-Market | 5.75% | 6.71% | 1.17x | Exceeded |
| 2024-05-02 | Pre-Market | 6.72% | 5.51% | 0.82x | Within |
| 2024-08-06 | Pre-Market | 9.10% | 5.99% | 0.66x | Within |
| 2024-11-04 | Pre-Market | 7.47% | 3.72% | 0.50x | Within |
| 2025-02-13 | Pre-Market | 7.07% | 5.15% | 0.73x | Within |
| 2025-05-06 | Pre-Market | 7.15% | 5.18% | 0.72x | Within |
| 2025-08-05 | Pre-Market | 7.21% | 3.75% | 0.52x | Within |
| 2025-11-04 | Pre-Market | 7.55% | 13.78% | 1.83x | Exceeded |
| 2026-02-12 | Pre-Market | 8.28% | 2.35% | 0.28x | Within |
| 2026-05-07 | Pre-Market | 8.81% | 21.50% | 2.44x | Exceeded |
| 2026-08-06 | Pre-Market | 12.23% | 3.87% | 0.32x | Within |
| 2026-11-05 | Pre-Market | 10.43% | 7.95% | 0.76x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
ZTS Options Activity & IV Rank
ZTS IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 36.7%
7-DTE IV: 38.2%
Expected Move: $7.80
7-DTE Move: $4.78
Days to Exp: 42 (2026-12-18)
Options Flow
Call Volume: 616
Put Volume: 429
P/C Volume: 0.696
BULLISH
Call OI: 7,643
Put OI: 10,480
P/C OI: 1.371
Total OI: 18,123
ATM Options Pricing
ATM Call: $4.05
ATM Put: $3.75
Call %: 5.1%
Put %: 4.7%
Chain Summary
Chain Volume: 5,158
Chain OI: 166,096
Last Updated: 11/6/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 60th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
60%
vs own history
GEX tilt
+0.10
OI-weighted, today
Vanna tilt
+0.66
δ-sensitivity to IV
Charm tilt
-0.62
δ-decay vs time
Vanna tilt +0.66: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.62: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 29 ATM contracts, 38k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM 38.2% / Wing —
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)19.4LowNov 6
IV Rank (30 DTE)22.3LowNov 6
Straddle Price (30 DTE)$7.80Nov 6
Beta Analysis
Risk Metrics
Beta: 0.5753
Alpha: -38.50%
Correlation: 0.2062
R-Squared: 4.3%
Stock Volatility: 37.9%
Market Volatility: 13.6%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ZTS
7 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $229.1M | #161 of 6285 | +536.4% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $130.3M | #260 of 3716 | +9.9% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $100.8M | #155 of 3138 | +456.9% | 13F | |
| Markel Group Holding company Tom Gayner | $29.7M | #75 of 145 | +542.5% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $23.7M | #435 of 4729 | +30.5% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $9.6M | #341 of 997 | +164.5% | 13F | |
| Soros Fund Management Family office George Soros, Robert Soros, Jonathan Soros | $2.0M | #195 of 251 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ZTS Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 438,733,750 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
43 filers$418.65M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $81.50M | 19.47% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $56.07M | 13.39% | 2026-06-30 |
| 3 | TORONTO DOMINION BANK | $43.12M | 10.30% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $36.06M | 8.61% | 2026-06-30 |
| 5 | Goldman Sachs Group Inc Custodian | $35.84M | 8.56% | 2026-06-30 |
| 6 | Wolverine Trading, LLC Custodian | $20.64M | 4.93% | 2025-09-30 |
| 7 | Rule One Partners, LLC | $18.06M | 4.31% | 2026-06-30 |
| 8 | Squarepoint Ops LLC | $17.11M | 4.09% | 2026-06-30 |
| 9 | IMC-Chicago, LLC Custodian | $14.38M | 3.43% | 2026-06-30 |
| 10 | Walleye Capital LLC | $12.45M | 2.97% | 2026-06-30 |
| 11 | Simplex Trading, LLC Custodian | $11.54M | 2.76% | 2026-06-30 |
| 12 | Citigroup Inc. Custodian | $10.78M | 2.57% | 2026-06-30 |
| 13 | Millennium Management LLC Custodian | $9.14M | 2.18% | 2026-06-30 |
| 14 | TUDOR INVESTMENT CORP ET AL | $8.04M | 1.92% | 2026-06-30 |
| 15 | Caption Management, LLC | $7.19M | 1.72% | 2026-06-30 |
| 16 | GROUP ONE TRADING LLC Custodian | $6.04M | 1.44% | 2026-06-30 |
| 17 | CAPITAL FUND MANAGEMENT S.A. | $4.74M | 1.13% | 2026-06-30 |
| 18 | CastleKnight Management LP | $3.59M | 0.86% | 2026-06-30 |
| 19 | Royal Bank of Canada Custodian | $3.56M | 0.85% | 2026-06-30 |
| 20 | Maven Securities LTD | $3.55M | 0.85% | 2026-06-30 |
| 21 | Allianz Asset Management GmbH | $3.24M | 0.77% | 2026-06-30 |
| 22 | Point72 Asset Management, L.P. | $2.29M | 0.55% | 2026-06-30 |
| 23 | Two Sigma Investments, LP Custodian | $1.74M | 0.42% | 2026-06-30 |
| 24 | Vontobel Holding Ltd. | $1.26M | 0.30% | 2026-09-30 |
| 25 | Qube Research & Technologies Ltd | $1.19M | 0.28% | 2026-06-30 |
30 filers$376.93M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $109.29M | 29.00% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $77.80M | 20.64% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $64.26M | 17.05% | 2026-06-30 |
| 4 | IMC-Chicago, LLC Custodian | $18.30M | 4.86% | 2026-06-30 |
| 5 | GROUP ONE TRADING LLC Custodian | $17.89M | 4.75% | 2026-06-30 |
| 6 | Wolverine Trading, LLC Custodian | $16.57M | 4.40% | 2025-09-30 |
| 7 | Simplex Trading, LLC Custodian | $11.53M | 3.06% | 2026-06-30 |
| 8 | Walleye Capital LLC | $8.49M | 2.25% | 2026-06-30 |
| 9 | Squarepoint Ops LLC | $5.84M | 1.55% | 2026-06-30 |
| 10 | TUDOR INVESTMENT CORP ET AL | $5.02M | 1.33% | 2026-06-30 |
| 11 | Millennium Management LLC Custodian | $4.85M | 1.29% | 2026-06-30 |
| 12 | D. E. Shaw & Co., Inc. Custodian | $4.58M | 1.22% | 2026-06-30 |
| 13 | Point72 Asset Management, L.P. | $4.56M | 1.21% | 2026-06-30 |
| 14 | Allianz Asset Management GmbH | $3.92M | 1.04% | 2026-06-30 |
| 15 | Maven Securities LTD | $3.75M | 0.99% | 2026-06-30 |
| 16 | Royal Bank of Canada Custodian | $3.05M | 0.81% | 2026-06-30 |
| 17 | Goldman Sachs Group Inc Custodian | $2.69M | 0.71% | 2026-06-30 |
| 18 | CAPITAL FUND MANAGEMENT S.A. | $2.44M | 0.65% | 2026-06-30 |
| 19 | Walleye Trading LLC | $2.26M | 0.60% | 2026-06-30 |
| 20 | Eisler Capital Management Ltd. | $2.15M | 0.57% | 2025-09-30 |
| 21 | Two Sigma Investments, LP Custodian | $1.88M | 0.50% | 2026-06-30 |
| 22 | CAPSTONE INVESTMENT ADVISORS, LLC | $1.88M | 0.50% | 2026-06-30 |
| 23 | SG Americas Securities, LLC | $1.35M | 0.36% | 2026-06-30 |
| 24 | Twin Tree Management, LP | $876.69K | 0.23% | 2026-06-30 |
| 25 | Vontobel Holding Ltd. | $488.81K | 0.13% | 2026-09-30 |
ZTS Insider Trading (Form 4)
Latest: 2026-11-03Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-03 | Mark Stetter | Director | Grant (A) | +5 RSU | — | EDGAR | |
| 2026-10-13 | Keith Sarbaugh | Executive Vice President | Grant (A) | +303 RSU | — | EDGAR | |
| 2026-10-13 | Julie Fuller | Executive Vice President | Grant (A) | +367 RSU | — | EDGAR | |
| 2026-10-13 | Astorga Jeannette Ferran | Executive Vice President | Grant (A) | +52 RSU | — | EDGAR | |
| 2026-10-13 | Kevin Esch | Executive Vice President | Grant (A) | +360 RSU | — | EDGAR | |
| 2026-10-13 | Rimma Driscoll | Executive Vice President | Grant (A) | +277 RSU | — | EDGAR | |
| 2026-10-13 | Abhay U Nayak | Executive Vice President | Grant (A) | +321 RSU | — | EDGAR | |
| 2026-10-13 | Kristin C Peck | Chief Executive Officer | Grant (A) | +720 RSU | — | EDGAR | |
| 2026-10-13 | Roxanne Lagano | Executive Vice President | Grant (A) | +367 RSU | — | EDGAR | |
| 2026-10-02 | Julie Fuller | Executive Vice President | Mixed | +525 | $69.83 | -$19.1K | EDGAR |
| 2026-09-18 | Mark Stetter | Director | Grant (A) | +342 RSU | — | EDGAR | |
| 2026-09-02 | James Saccaro | EVP, CFO & COO | Grant (A) | +81,063 RSU | — | EDGAR | |
| 2026-08-11 | Frank A Damelio | Director | Gift (G) | −6,650 | — | EDGAR | |
| 2026-07-14 | Abhay U Nayak | Executive Vice President | Grant (A) | +214 RSU | — | EDGAR | |
| 2026-07-14 | Roxanne Lagano | Executive Vice President | Grant (A) | +314 RSU | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ZTS Insider Holdings
24 insiders · @ $80.36
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Kristin C Peck | Chief Executive Officer | 109,524 | $8.80M | -$43.35M | 128 | 2026-10-13 |
| 2 | Michael B McCallister | Director | 31,893 | $2.56M | $555.4K | 34 | 2026-06-11 |
| 3 | Paul Bisaro | Director | 27,862 | $2.24M | $151.8K | 24 | 2026-05-13 |
| 4 | Wetteny Joseph | Chief Financial Officer | 22,113 | $1.78M | $0 | 36 | 2026-07-14 |
| 5 | Frank A Damelio | Director | 21,458 | $1.72M | $631.3K | 30 | 2026-08-11 |
| 6 | Louise M Parent | Director | 18,208 | $1.46M | $0 | 50 | 2026-05-21 |
| 7 | Roxanne Lagano | Executive Vice President | 16,465 | $1.32M | -$28.76M | 145 | 2026-10-13 |
| 8 | Robert W Scully | Director | 13,145 | $1.06M | $1.25M | 36 | 2025-05-23 |
| 9 | Willie M Reed | Director | 12,864 | $1.03M | -$1.86M | 31 | 2026-02-23 |
| 10 | Gregory Norden | Director | 7,071 | $568.2K | -$894.3K | 36 | 2026-03-10 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ZTS Board & Officers
As of SEC filings through Nov 3, 2026Directors 12
- Frank A Damelio · since Jan 31, 2013
- Gregory Norden · since Jan 31, 2013
- Michael B McCallister · since Jan 31, 2013
- Khosla Sanjay · since Jun 27, 2013
- Willie M Reed · since Mar 4, 2014
- Paul Bisaro · since May 1, 2015
- Kristin C Peck · listed since Oct 2019
- Antoinette Renee Leatherberry · since Dec 8, 2020
- Vanessa Broadhurst · since Jul 25, 2022
- Gavin Hattersley · since Apr 1, 2024
- Mark Stetter · since May 21, 2025
- Stephanie Tilenius · since Dec 1, 2025
Officers 12
- Kristin C Peck · Chief Executive Officer · listed since Jan 2020
- Roxanne Lagano · Executive Vice President · since Jan 31, 2013
- Abhay U Nayak · Executive Vice President · listed since Feb 2021
- Astorga Jeannette Ferran · Executive Vice President · since Jan 1, 2022
- Robert J Polzer · Executive Vice President · since Jan 1, 2022
- Nicholas Ashton · Executive Vice President · since Jun 1, 2022
- Jamie Brannan · Executive Vice President · since Nov 1, 2022
- Rimma Driscoll · Executive Vice President · since Nov 1, 2022
- Julie Fuller · Executive Vice President · since Sep 3, 2024
- Keith Sarbaugh · Executive Vice President · since Nov 11, 2024
- Kevin Esch · Executive Vice President · since Jan 1, 2026
- James Saccaro · EVP, CFO & COO · since Aug 17, 2026
Changes in the last 10 years (36)
| Aug 17, 2026 | James Saccaro became EVP, CFO & COO |
| Jul 31, 2026 | The company announced the departure of Wetteny Joseph as Chief Financial Officer in an SEC filing |
| May 21, 2026 | Louise M Parent reported in an SEC filing no longer being a director |
| Jan 1, 2026 | Kevin Esch became Executive Vice President |
| Dec 1, 2025 | Stephanie Tilenius became a director |
| May 23, 2025 | Robert W Scully reported in an SEC filing no longer being a director |
| May 21, 2025 | Mark Stetter became a director |
| Nov 11, 2024 | Keith Sarbaugh became Executive Vice President |
| Sep 3, 2024 | Julie Fuller became Executive Vice President |
| May 22, 2024 | Linda Rhodes reported in an SEC filing no longer being a director |
| Apr 1, 2024 | Gavin Hattersley became a director |
| Jul 10, 2023 | Soria Ester Banque became Executive Vice President |
| Nov 1, 2022 | Rimma Driscoll became Executive Vice President |
| Nov 1, 2022 | Jamie Brannan became Executive Vice President |
| Jul 25, 2022 | Vanessa Broadhurst became a director |
| Jun 1, 2022 | Nicholas Ashton became Executive Vice President |
| Apr 19, 2022 | The company announced the departure of Roman Trawicki as Executive Vice President in an SEC filing |
| Jan 1, 2022 | Robert J Polzer became Executive Vice President |
| Jan 1, 2022 | Astorga Jeannette Ferran became Executive Vice President |
| Jul 20, 2021 | Glenn David listed as Executive Vice President (previously Chief Financial Officer) in SEC filings |
| Jun 1, 2021 | Wetteny Joseph became Chief Financial Officer |
| May 24, 2021 | William C Steere Jr reported in an SEC filing no longer being a director |
| May 24, 2021 | Juan Ramon Alaix reported in an SEC filing no longer being a director |
| Feb 12, 2021 | Abhay U Nayak listed as Executive Vice President (previously Senior Vice President) in SEC filings |
| Dec 8, 2020 | Antoinette Renee Leatherberry became a director |
| Mar 9, 2020 | Sherry N Pudloski became Executive Vice President |
| Jan 28, 2020 | Wafaa Mamilli became Executive Vice President |
| Jan 22, 2020 | James Michael McFarland became Executive Vice President |
| Jan 14, 2020 | Kristin C Peck listed as Chief Executive Officer (previously Executive Vice President) in SEC filings |
| Jan 14, 2020 | Juan Ramon Alaix no longer listed as Chief Executive Officer in SEC filings |
| Jan 1, 2020 | Timothy J Bettington became Executive Vice President |
| Jan 1, 2020 | Robert Edward Kelly became Executive Vice President |
| Jan 1, 2020 | Abhay U Nayak became Senior Vice President |
| Oct 15, 2019 | Kristin C Peck first listed as a director in an SEC filing |
| Mar 1, 2018 | Alejandro Bernal reported in an SEC filing no longer being Executive Vice President |
| Aug 3, 2017 | Linda Rhodes became a director |
Not reported recently (11)
- Wafaa Mamilli · Last reported as Executive Vice President in an SEC filing dated Oct 8, 2024
- Soria Ester Banque · Last reported as Executive Vice President in an SEC filing dated Oct 8, 2024
- Heidi C. Chen · Last reported as Executive Vice President in an SEC filing dated Apr 9, 2024
- Glenn David · Last reported as Executive Vice President in an SEC filing dated Jan 18, 2023
- Timothy J Bettington · Last reported as Executive Vice President in an SEC filing dated Oct 11, 2022
- Catherine A. Knupp · Last reported as Executive Vice President in an SEC filing dated Nov 12, 2021
- Sherry N Pudloski · Last reported as Executive Vice President in an SEC filing dated Oct 12, 2021
- Robert Edward Kelly · Last reported as Executive Vice President in an SEC filing dated May 4, 2021
- James Michael McFarland · Last reported as Executive Vice President in an SEC filing dated Apr 13, 2021
- Clinton A. Lewis Jr. · Last reported as Executive Vice President in an SEC filing dated Dec 18, 2019
- Andrew Fenton · Last reported as Executive Vice President in an SEC filing dated Dec 10, 2019
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ZTS Proposed Insider Sales (Form 144)
Latest: 2026-02-17
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | Polzer Robert J | Officer | 2,346 | $298.7K | 2026-02-17 | Merrill Lynch | — | EDGAR |
| 2026-02-17 | PECK KRISTIN C | Officer | 20,000 | $2.54M | 2026-02-17 | Merrill Lynch | 10b5-1 | EDGAR |
| 2026-02-13 | Polzer Robert J | Officer | 3,662 | $472.7K | 2026-02-13 | Merrill Lynch | — | EDGAR |
| 2025-06-03 | Lagano Roxanne | Officer | 652 | $110.8K | 2025-06-03 | Merrill Lynch | 10b5-1 | EDGAR |
| 2025-03-11 | Reed Willie M | Director | 1,210 | $201.0K | 2025-03-11 | Merrill Lynch | — | EDGAR |
| 2025-03-10 | Lagano Roxanne | Officer | 326 | $55.4K | 2025-03-10 | Merrill Lynch | 10b5-1 | EDGAR |
| 2025-02-19 | PECK KRISTIN C | Officer, Director | 382 | $59.9K | 2025-02-19 | Merrill Lynch | 10b5-1 | EDGAR |
| 2025-02-11 | Lagano Roxanne | Officer | 326 | $55.8K | 2025-02-11 | Merrill Lynch | 10b5-1 | EDGAR |
| 2024-11-25 | Polzer Robert J | Officer | 3,477 | $617.0K | 2024-11-25 | Merrill Lynch | — | EDGAR |
| 2024-05-07 | Chen Heidi C. | Officer | 17,100 | $2.88M | 2024-05-07 | Merrill Lynch | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-22
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-22 | 0001555280-26-000029 | EDGAR |
| 2026-05-20 | 0001555280-26-000026 | EDGAR |
| 2026-05-07 | 0001555280-26-000021 | EDGAR |
| 2026-02-12 | 0001555280-26-000008 | EDGAR |
| 2026-02-05 | 0001555280-26-000003 | EDGAR |
| 2025-12-18 | 0001193125-25-324853 | EDGAR |
| 2025-12-11 | 0001555280-25-000282 | EDGAR |
| 2025-12-02 | 0001555280-25-000280 | EDGAR |
| 2025-11-04 | 0001555280-25-000272 | EDGAR |
| 2025-10-28 | 0001555280-25-000266 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-07 | 0001555280-26-000024 | EDGAR |
| 2025-11-04 | 0001555280-25-000274 | EDGAR |
| 2025-08-05 | 0001555280-25-000261 | EDGAR |
| 2025-05-06 | 0001555280-25-000203 | EDGAR |
| 2024-11-04 | 0001555280-24-000332 | EDGAR |
| 2024-08-06 | 0001555280-24-000299 | EDGAR |
| 2024-05-02 | 0001555280-24-000249 | EDGAR |
| 2023-11-02 | 0001555280-23-000247 | EDGAR |
| 2023-08-08 | 0001555280-23-000205 | EDGAR |
| 2023-05-04 | 0001555280-23-000150 | EDGAR |
ETF Holders
352 ETFs hold ZTS
25 shown · $5.90B total exposure · 0.11% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.04% | $824.8M | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.04% | $757.7M | — | 2026-09-30 |
| 3 | VO Vanguard Morningstar Mid-Cap ETF | Vanguard | 0.26% | $556.1M | — | 2026-09-30 |
| 4 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.06% | $494.1M | $850.0B | 2026-11-04 |
| 5 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.06% | $455.0M | $818.5B | 2026-11-04 |
| 6 | MOAT VanEck Morningstar Wide Moat ETF | VanEck | 2.69% | $330.2M | $12.0B | 2026-11-04 |
| 7 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.54% | $272.9M | $50.9B | 2026-11-04 |
| 8 | VTV Vanguard Morningstar Value ETF | Vanguard | 0.10% | $247.4M | — | 2026-09-30 |
| 9 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.23% | $242.8M | — | 2026-11-04 |
| 10 | IWP iShares Russell Mid-Cap Growth ETF | iShares (BlackRock) | 0.91% | $166.4M | $18.3B | 2026-11-04 |
| 11 | VIG Vanguard Dividend Appreciation ETF | Vanguard | 0.13% | $163.3M | — | 2026-09-30 |
| 12 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.27% | $159.8M | $56.8B | 2026-11-04 |
| 13 | VYM Vanguard High Dividend Yield ETF | Vanguard | 0.12% | $119.5M | — | 2026-09-30 |
| 14 | COWZ Pacer US Cash Cows 100 ETF | Nport | 0.62% | $116.2M | — | 2026-07-31 |
| 15 | IWF iShares Russell 1000 Growth ETF | iShares (BlackRock) | 0.09% | $111.3M | $112.9B | 2026-11-04 |
| 16 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.06% | $102.7M | $185.1B | 2026-11-04 |
| 17 | VOT Vanguard Morningstar Mid-Cap Growth ETF | Vanguard | 0.31% | $101.9M | — | 2026-09-30 |
| 18 | DGRO iShares Core Dividend Growth ETF | iShares (BlackRock) | 0.22% | $101.5M | $44.9B | 2026-11-04 |
| 19 | VFLO VictoryShares Free Cash Flow ETF | Nport | 1.26% | $97.8M | — | 2026-06-30 |
| 20 | VHT Vanguard Health Care ETF | Vanguard | 0.41% | $89.4M | — | 2026-09-30 |
| 21 | IHE iShares U.S. Pharmaceuticals ETF | iShares (BlackRock) | 5.12% | $84.8M | $1.6B | 2026-11-04 |
| 22 | VOE Vanguard Morningstar Mid-Cap Value ETF | Vanguard | 0.22% | $81.1M | — | 2026-09-30 |
| 23 | QUAL iShares MSCI USA Quality Factor ETF | iShares (BlackRock) | 0.16% | $80.5M | $47.5B | 2026-11-04 |
| 24 | MOO VanEck Agribusiness ETF | VanEck | 7.03% | $78.5M | $1.1B | 2026-11-04 |
| 25 | SPHQ Invesco S&P 500 Quality ETF | Invesco | 0.36% | $68.1M | — | 2026-11-04 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
13.32
TTM Diluted EPS
$6.03
TTM Revenue
$9.51B
TTM Net Income
$2.64B
TTM Op. Cash Flow
$2.72B
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $2.26B | $601.00M | $1.42 | $401.00M |
| Q4 '25 | 2025-12-31 | $2.39B | $603.00M | $1.37 | $893.00M |
| Q3 '25 | 2025-09-30 | $2.40B | $721.00M | $1.63 | $938.00M |
| Q2 '25 | 2025-06-30 | $2.46B | $718.00M | $1.61 | $486.00M |
| Q1 '25 | 2025-03-31 | $2.20B | $602.00M | $1.34 | $515.00M |
| Q4 '24 | 2024-12-31 | $2.32B | $581.00M | $1.29 | $905.00M |
| Q3 '24 | 2024-09-30 | $2.39B | $682.00M | $1.50 | $951.00M |
| Q2 '24 | 2024-06-30 | $2.36B | $624.00M | $1.37 | $502.00M |
| Q1 '24 | 2024-03-31 | $2.19B | $599.00M | $1.31 | $595.00M |
| Q4 '23 | 2023-12-31 | $2.21B | $525.00M | $1.14 | $897.00M |
| Q3 '23 | 2023-09-30 | $2.15B | $596.00M | $1.29 | $724.00M |
| Q2 '23 | 2023-06-30 | $2.18B | $671.00M | $1.45 | $183.00M |
Q1 2026 • period ending 2026-03-31 • filed 2026-05-07
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
13.32
P/B
10.90
P/S
3.71
EV/EBITDA
10.43
EV/Sales
4.45
ROE
81.8%
ROA
17.4%
Div Yield
2.41%
FCF Yield
7.71%
Debt/Equity
2.80
Current Ratio
—
Market Cap
$35.24B
as of 2026-11-06
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
17.52M
SI % of Float
4.24%
Days to Cover
4.06
Short Vol Ratio
41.6%
Free Float
412.93M
Float %
99.9%
Short interest 2026-10-15 • Short volume 2026-11-05 • Float 2026-09-24